Journal of Oncology

Papillomavirus from the Bench to the Clinics


Publishing date
01 Apr 2012
Status
Published
Submission deadline
01 Oct 2011

1Laboratory of Medical Investigation (LIM) 14, Faculty of Medicine, University of São Paulo, 01246903 São Paulo, SP, Brazil; and Life and Health Sciences Research Institute, School of Health Sciences, University of Minho, Portugal - Campos of Gualtar, 4710-057 Braga, Portugal

2Ludwig Institute for Cancer Research - Hospital Alemão Oswaldo Cruz; R. João Julião, 245 - 1° andar, 01323-930 São Paulo, SP, Brazil


Papillomavirus from the Bench to the Clinics

Description

Certain human papillomavirus (HPV) are currently recognized as viral carcinogenic agent involved with cancer development, where women cervical cancer is the prototype of HPV-induced malignancy. Other carcinomas as occur in penis, vulva, vagina, and head and neck location are also related to the persistent HPV infection, but different degrees of association if compared with cervical cancer. A plethora of novelties in the HPV setting have emerged, recently. One of the most exciting topics was the introduction of HPV vaccines principally tailored to two of the most important carcinogenic HPV: HPV16 and HPV18. The vaccines have encouraged many public health authorities to implement primary prevention in order to minimize to cervical cancer burden. HPV6 and HPV11, also included in one of the vaccines currently available, also target benign proliferative lesions from genital and respiratory tracts.

Additionally, new technologies to optimize cytological and molecular screening have been implemented in many countries in the last decade, which demonstrated a significant improvement in high grade lesions detection.

We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand the molecular pathways underlying HPV biology and cancer development, the development of strategies to prevent and treat these conditions, and also the evaluation of outcomes. We are particularly interested in articles describing the new modalities for basic and clinical characterization of HPV biology and measuring outcomes from treatment trials, advances in molecular genetics and molecular diagnostics, advances in immunology related to HPV infection, potential usefulness of specific target therapies to HPV-induced lesions, new insights into HPV epidemiologic distribution worldwide, animal models, the relationship between HPV-infected cells and microenvironment, molecular markers, strategies of HPV-induced lesions in low income countries/regions, and HPV and head and neck cancer. Potential topics include, but are not limited to:

  • Recent developments in HPV basic research
  • Advances in the studies of microenvironment influences for HPV infection
  • Latest technologies for clinical and pathological evaluation and measuring outcomes
  • Role of inflammation in HPV infection
  • Disease molecular mechanism and potential targets to blocking HPV-induced lesion development
  • Role of molecular tests in screening routine
  • Recent advances in automation for cytological screening
  • Recent advances in therapeutics
  • Role of HPV in head and neck cancer
  • HPV and other cancers

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jo/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 437438
  • - Editorial

Papillomavirus from the Bench to the Clinics

Adhemar Longatto Filho | Luisa Lina Villa | Kari Syrjänen
  • Special Issue
  • - Volume 2012
  • - Article ID 728397
  • - Research Article

Burden of Human Papillomavirus among Haitian Immigrants in Miami, Florida: Community-Based Participatory Research in Action

Erin Kobetz | Jonathan K. Kish | ... | Lindley Barbee
  • Special Issue
  • - Volume 2012
  • - Article ID 289315
  • - Review Article

Role of Protein Biomarkers in the Detection of High-Grade Disease in Cervical Cancer Screening Programs

Charlotte A. Brown | Johnannes Bogers | ... | Douglas P. Malinowski
  • Special Issue
  • - Volume 2012
  • - Article ID 542851
  • - Review Article

Lm-LLO-Based Immunotherapies and HPV-Associated Disease

Anu Wallecha | Chris French | ... | John Rothman
  • Special Issue
  • - Volume 2012
  • - Article ID 750270
  • - Review Article

Lung Cancer and Human Papilloma Viruses (HPVs): Examining the Molecular Evidence

Priya R. Prabhu | D. Jayalekshmi | M. Radhakrishna Pillai
  • Special Issue
  • - Volume 2012
  • - Article ID 571862
  • - Research Article

Complex Etiology Underlies Risk and Survival in Head and Neck Cancer Human Papillomavirus, Tobacco, and Alcohol: A Case for Multifactor Disease

Elaine M. Smith | Linda M. Rubenstein | ... | Lubomir P. Turek
  • Special Issue
  • - Volume 2012
  • - Article ID 905024
  • - Research Article

Towards a “Sample-In, Answer-Out” Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model System

Anja Gulliksen | Helen Keegan | ... | Liv Furuberg
  • Special Issue
  • - Volume 2012
  • - Article ID 278312
  • - Review Article

Molecular Mechanism and Potential Targets for Blocking HPV-Induced Lesion Development

E. Guzmán-Olea | V. H. Bermúdez-Morales | ... | V. Madrid-Marina
  • Special Issue
  • - Volume 2012
  • - Article ID 904034
  • - Research Article

Adolescent Understanding and Acceptance of the HPV Vaccination in an Underserved Population in New York City

Jill Blumenthal | Melissa K. Frey | ... | Brian M. Slomovitz
  • Special Issue
  • - Volume 2012
  • - Article ID 893275
  • - Research Article

Human Papillomavirus Genotyping and E6/E7 mRNA Expression in Greek Women with Intraepithelial Neoplasia and Squamous Cell Carcinoma of the Vagina and Vulva

Elpida Tsimplaki | Elena Argyri | ... | Efstathia Panotopoulou
Journal of Oncology
 Journal metrics
Acceptance rate24%
Submission to final decision66 days
Acceptance to publication37 days
CiteScore3.100
Journal Citation Indicator0.680
Impact Factor4.375
 Submit

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.